Skip to content
healthcare.dev

Labetalol Hydrochloride

NDC 71247-130, Labetalol Hydrochloride, tablet, film coated, from Innogenix, Inc..

Product NDC
71247-130
Status
Listed
Labeler
Innogenix, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075215
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71247-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LABETALOL HYDROCHLORIDE300 mg/1

Pharmacologic classes

Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
71247-130-0171247013001100 TABLET, FILM COATED in 1 BOTTLE (71247-130-01)
71247-130-0571247013005500 TABLET, FILM COATED in 1 BOTTLE (71247-130-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/82fc2d64-0572-4a9b-94fc-f6eb8d930c54

Use it

Look up 71247-130 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71247-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71247-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.